148 related articles for article (PubMed ID: 2964972)
1. Changes in atrial natriuretic factor during preload reduction with nitroglycerin in patients with congestive heart failure.
Keller N; Sykulski R; Thamsborg G; Storm T; Larsen J
Clin Physiol; 1988 Feb; 8(1):57-64. PubMed ID: 2964972
[TBL] [Abstract][Full Text] [Related]
2. Effect of reducing atrial pressure on atrial natriuretic factor and vasoactive hormones in congestive heart failure secondary to ischemic and nonischemic dilated cardiomyopathy.
Webster MW; Sharpe DN; Coxon R; Murphy J; Hannan S; Nicholls MG; Espiner EA
Am J Cardiol; 1989 Jan; 63(3):217-21. PubMed ID: 2521271
[TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic factor during exercise in patients with congestive heart failure.
Keller N; Larsen J; Sykulski R; Storm T; Thamsborg G
Acta Endocrinol (Copenh); 1988 Jun; 118(2):168-72. PubMed ID: 2968748
[TBL] [Abstract][Full Text] [Related]
4. Effects of dobutamine and salbutamol on haemodynamics and atrial natriuretic factor in patients with severe congestive heart failure.
Keller N; Sykulski R; Larsen J
Clin Physiol; 1991 May; 11(3):199-210. PubMed ID: 1832602
[TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic peptide in severe heart failure: response to controlled changes in atrial pressures during intravenous nitroglycerin therapy.
Lewis BS; Makhoul N; Dakak N; Flugelman MY; Yechiely H; Halon DA; Kahana L
Am Heart J; 1992 Oct; 124(4):1009-16. PubMed ID: 1388322
[TBL] [Abstract][Full Text] [Related]
6. Different hemodynamic effects of atrial natriuretic factor and nitroglycerin in rats with congestive heart failure.
Chien YW; Trippodo NC; Frohlich ED
Am J Physiol; 1989 Dec; 257(6 Pt 2):R1481-7. PubMed ID: 2532483
[TBL] [Abstract][Full Text] [Related]
7. Atrial natriuretic factor, cardiac volumes and filling pressures during exercise in congestive heart failure.
Donckier JE; De Coster PM; Vanoverschelde JL; Brichant C; Cauwe F; Installe E; Berbinschi A; Ketelslegers JM; Marchandise B
Eur Heart J; 1991 Mar; 12(3):332-7. PubMed ID: 1828231
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms involved in the response to prolonged infusion of atrial natriuretic factor in patients with chronic heart failure.
Münzel T; Drexler H; Holtz J; Kurtz S; Just H
Circulation; 1991 Jan; 83(1):191-201. PubMed ID: 1845857
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic and neurohumoral responses to intravenous nicorandil in congestive heart failure in humans.
Giles TD; Pina IL; Quiroz AC; Roffidal L; Zaleski R; Porter RS; Karalis DG; Mohrland JS; Wolf DL; Hearron AE
J Cardiovasc Pharmacol; 1992 Oct; 20(4):572-8. PubMed ID: 1280713
[TBL] [Abstract][Full Text] [Related]
10. Cardiac secretion of atrial natriuretic factor with exercise in chronic congestive heart failure patients.
Cody RJ; Kubo SH; Laragh JH; Atlas SA
J Appl Physiol (1985); 1992 Oct; 73(4):1637-43. PubMed ID: 1360003
[TBL] [Abstract][Full Text] [Related]
11. Influence of dilated cardiomyopathy, myocarditis and cardiac transplantation on the relation between plasma atrial natriuretic factor and atrial pressures.
Hare JM; Baughman KL; Kass DA; Goodman SN; Ladenson PW
Am J Cardiol; 1991 Feb; 67(5):391-7. PubMed ID: 1825259
[TBL] [Abstract][Full Text] [Related]
12. Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure.
Tsutamoto T; Kanamori T; Wada A; Kinoshita M
J Am Coll Cardiol; 1992 Sep; 20(3):541-6. PubMed ID: 1324959
[TBL] [Abstract][Full Text] [Related]
13. Interaction of intravenous atrial natriuretic factor with furosemide in patients with heart failure.
Connelly TP; Francis GS; Williams KJ; Beltran AM; Cohn JN
Am Heart J; 1994 Feb; 127(2):392-9. PubMed ID: 8296708
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure.
Raine AE; Erne P; Bürgisser E; Müller FB; Bolli P; Burkart F; Bühler FR
N Engl J Med; 1986 Aug; 315(9):533-7. PubMed ID: 2942777
[TBL] [Abstract][Full Text] [Related]
15. Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure.
Kubo SH; Fox SC; Prida XE; Cody RJ
Am Heart J; 1985 Nov; 110(5):1032-4. PubMed ID: 3933315
[TBL] [Abstract][Full Text] [Related]
16. Effect of low dose beta blockers on atrial and ventricular (B type) natriuretic factor in heart failure: a double blind, randomised comparison of metoprolol and a third generation vasodilating beta blocker.
Sanderson JE; Chan WW; Hung YT; Chan SK; Shum IO; Raymond K; Woo KS
Br Heart J; 1995 Nov; 74(5):502-7. PubMed ID: 8562234
[TBL] [Abstract][Full Text] [Related]
17. Influence of angiotensin converting enzyme inhibition on relation of atrial natriuretic peptide concentration to atrial pressure in heart failure.
Berglund H; Nyquist O; Beermann B; Jensen-Urstad M; Theodorsson E
Br Heart J; 1994 Dec; 72(6):521-7. PubMed ID: 7857733
[TBL] [Abstract][Full Text] [Related]
18. Prolonged hemodynamic benefits from a high-dose bolus injection of human atrial natriuretic factor in congestive heart failure.
Giles TD; Quiroz AC; Roffidal LE; Marder H; Sander GE
Clin Pharmacol Ther; 1991 Nov; 50(5 Pt 1):557-63. PubMed ID: 1834391
[TBL] [Abstract][Full Text] [Related]
19. [Atrial natriuretic factor levels and pressure in the pulmonary circulation before and after coronary dilatation].
Scholz KH; Marten J; Herrmann C; Spaar U; Tebbe U; Neuhaus KL; Kreuzer H
Klin Wochenschr; 1990 Aug; 68(16):823-9. PubMed ID: 2145466
[TBL] [Abstract][Full Text] [Related]
20. Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.
Yoshimura M; Yasue H; Tanaka H; Kikuta K; Sumida H; Kato H; Jougasaki M; Nakao K
Br Heart J; 1994 Dec; 72(6):528-33. PubMed ID: 7857734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
